Erbitux
Term · Oncology and biomedicine · MLC-T-ONC-002940
A drug used alone or with other drugs to treat certain types of head and neck cancer and colorectal cancer. It is also being studied in the treatment of other types of cancer. Erbitux binds to a protein called EGFR, which is found on some types of cancer cells. This may help keep cancer cells from growing. Erbitux is a type of monoclonal antibody. Also called cetuximab.
| Identifier | MLC-T-ONC-002940 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | cetuximab |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-002940",
"term": "Erbitux",
"field": "Oncology and biomedicine",
"definition": "A drug used alone or with other drugs to treat certain types of head and neck cancer and colorectal cancer. It is also being studied in the treatment of other types of cancer. Erbitux binds to a protein called EGFR, which is found on some types of cancer cells. This may help keep cancer cells from growing. Erbitux is a type of monoclonal antibody. Also called cetuximab.",
"synonyms": [
"cetuximab"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/erbitux/"
}
Record 6,835 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.